Bipartisan Bill Aims to Combat PBMs’ Medicaid Spread-Pricing
Drug Topics
MARCH 13, 2025
US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.
Thu.Mar 13, 2025
556 
Lawmakers tease out pharma’s influence over RFK Jr. through probe into Mar-a-Lago meetings
PharmaVoice
MARCH 13, 2025
HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Drug Shortages, Affordability Remain Top Concerns in Managed Care Pharmacy
Drug Topics
MARCH 13, 2025
Approximately, 62% of respondents stated that the number of active drug shortages could potentially increase by more than 25% within the next 5 years.
Takeda’s $770M deal deepens Big Pharma’s omics push
PharmaVoice
MARCH 13, 2025
The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Healthier Diet, Lower WHR Improved Cognitive Brain Function
Drug Topics
MARCH 13, 2025
Researchers compared changes in diet quality and waist-to-hip ratio during midlife with that of hippocampal connectivity and cognitive function in later life.
Counseling Patients About Pharmacologic Therapy for Menopausal Symptoms
Pharmacy Times
MARCH 13, 2025
Panelists discuss how health care professionals develop personalized menopause management strategies by comprehensively assessing individual medical history, symptom profiles, lifestyle factors, and potential risks. Through transparent, collaborative counseling, they guide patients in making informed decisions about pharmacologic therapies, prioritizing personalized care and holistic well-being.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Strategies For A Pharma Ad Ban on TV
Pharma Marketing Network
MARCH 13, 2025
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.
What Does the Future of Pain Medicine Look Like?
Drug Topics
MARCH 13, 2025
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
Pharmacy Cash Flow Pain Remains Even After The End Of The DIR Fee Apocalypse
DiversifyRx
MARCH 13, 2025
Pharmacy cash flow is still struggling even after the end of the DIR Fee Apocalypse DIR fees: the three letters that have kept pharmacy owners awake at night for years. Now that the so-called “DIR Fee Apocalypse” has come and gone, you might be thinking, “Finally, some relief!” But if youre anything like most independent pharmacy owners I talk to, youve realized that pharmacy cash flow problems dont magically disappear just because one storm has passed.
How to integrate AI in Pharma Marketing
Pharma Marketing Network
MARCH 13, 2025
Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Campus Preference and Assignment
Blog: Ask a Student Pharmacist
MARCH 13, 2025
Campus Preference and Assignment ceele001 Thu, 03/13/2025 - 15:22 The program is accredited for two performance sites, which include Rochester and the Twin Cities locations. Students can request the environment that best suits their needs. Our hybrid instruction model allows for faculty to teach the same courses and content at both performance sites.
An Overview of Vitamins and Supplements in Multiple Sclerosis
Pharmacy Times
MARCH 13, 2025
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Kelun-Biotech first to bag TROP2 approval in lung cancer
pharmaphorum
MARCH 13, 2025
Kelun-Biotech wins first global regulatory approval, in China, for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer
Expert: Pharmacists Play Crucial Role in Safe, Effective Elevidys Treatment in DMD
Pharmacy Times
MARCH 13, 2025
Pharmacists are crucial in Elevidys administration, ensuring accurate dosing, coordinating treatment timing, and managing adverse effects to optimize patient outcomes.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 13, 2025
A new report by Clearwater Security found that healthcare companies owned by private equity firms lack documented cybersecurity policies and incident response plans.
Updated CKD Guidelines Emphasize Implementation of Evidence-Based Approaches
Pharmacy Times
MARCH 13, 2025
Some of these approaches for chronic kidney disease (CKD) include cystatin C, SGLT2 inhibitors, point-of-care testing in remote areas, and acid-lowering medications.
Emergent signs financial investment agreement with Swiss Rockets
Pharmaceutical Technology
MARCH 13, 2025
Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latters biotech portfolio.
Genetic Study Sheds Light on Inherited Risk of Multiple Myeloma
Pharmacy Times
MARCH 13, 2025
Approximately 10% of patients with multiple myeloma have pathogenic germline variants, indicating a hereditary risk.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 13, 2025
Executives from the country's largest for-profit health systems say Congress is receptive to their lobbying against changes to Medicare and Medicaid but acknowledge that some level of reform is likely in their future and will require operational pivots.
Impact of Time to First Epinephrine Administration on Outcomes After In-Hospital Cardiac Arrest With Initial Nonshockable Rhythm
Pharmacy Times
MARCH 13, 2025
This study found no significant difference in the sustained return of spontaneous circulation or survival to hospital discharge based on the timing of the first epinephrine administration in these patients.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 13, 2025
A federal appeals court ruled that electronic health records company PointClickCare can't block health analytics firm Real Time Medical Systems from accessing patient data from its skilled nursing facility customers.
Poor Diet May Drive Lung Adenocarcinoma Progression Through Glycogen Accumulation
Pharmacy Times
MARCH 13, 2025
The Western diet was associated with increased risk of lung cancer.
Mallinckrodt and Endo sign $6.7bn merger deal
Pharmaceutical Technology
MARCH 13, 2025
The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.
National Institutes of Health Limits Grants for Vaccine Hesitancy Studies, Raising Questions About Future of Research
Pharmacy Times
MARCH 13, 2025
Reported terminations and limitations on research projects studying vaccine hesitancy and strategies to increase vaccine uptake are poised to greatly impact studies of the phenomenon.
Gedeon Richter’s once-daily endometriosis pill approved for NHS use
Pharmaceutical Technology
MARCH 13, 2025
NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.
Automation and New Technologies Are Pushing Pharmacy Forward
Pharmacy Times
MARCH 13, 2025
By saving time on mundane tasks, these tools allow pharmacists to focus on direct patient care.
Syngene Purchases First US Manufacturing Facility for $36.5M
Pharmaceutical Commerce
MARCH 13, 2025
The CRDMOs acquisition of the Baltimore plant is expected to boost its biologics presence.
Dietary, Lifestyle, and OTC Approaches for Managing Symptoms of Menopause
Pharmacy Times
MARCH 13, 2025
Panelists discuss how health care professionals recommend lifestyle modifications, dietary changes, and OTC products to manage menopause symptoms, focusing on exercise, nutrition, stress reduction, and targeted supplements to support overall well-being during this transitional period.
'Transformational' pill for endometriosis gets NHS nod
pharmaphorum
MARCH 13, 2025
Around 1,000 women in England a year with endometriosis will soon have access to the first daily oral therapy, Gedeon Richter's Ryeqo, via the NH
Personalizing ADC Therapy in mBC Based on Patient Characteristics and Prior Therapies
Pharmacy Times
MARCH 13, 2025
Panelists discuss how patient characteristics significantly impact antibody-drug conjugate (ADC) therapy selection, with key factors including the presence and location of brain metastases (due to blood-brain barrier penetration), organ function and comorbidities affecting toxicity risks, and prior treatment history that may influence both efficacy and safety.
Insilico raises $110m for AI-designed drug pipeline
pharmaphorum
MARCH 13, 2025
Insilico Medicine has raised $110 million in Series E funding for its artificial intelligence-powered drug discovery operations
Vivace closes $35m in Series D for cancer drug development
Pharmaceutical Technology
MARCH 13, 2025
Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug VT3989.
Rumour confirmed as Mallinckrodt merges with Endo
pharmaphorum
MARCH 13, 2025
Two companies forced to file for bankruptcy protection due to opioid litigation in the US Mallinckrodt and Endo have agreed to join forces via a $6.7 billion merger.
Let's personalize your content